Efficacy of physiotherapy in post-prostatectomy urinary incontinence

Effectiveness of a physiotherapy program in the treatment of urinary incontinence post-prostatectomy: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN48761809

Enrollment

134

Registered

2017-01-13

Start date

2015-02-15

Completion date

Unknown

Last updated

2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-prostatectomy urinary incontinence Surgery

Interventions

Participants are assigned to the control group or intervention group through simple randomization. Doctors, patients and evaluators will not be blinded. 1. Intervention: Biofeedback is used for the p

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Male patients intervened with radical prostatectomy 2. Incontinence (any loss of urine) 3. Erectile dysfunction, defined as a score under 21 in the International Index of Erectile Function (IIEF-5) 4. Over 18 years old

Exclusion criteria

Exclusion criteria: 1. Patients with neurological pathology (advanced Parkinson's, multiple sclerosis and disease with deterioration of cognitive or sensitive capacities or that course with muscle weakness) 2. Patients with serious disease processes such cancer, severe epoc, severe pulmonary hypertension 3. Patients with a pacemaker 4. Patients taking muscle relaxing medication 5. Patients with incotinence or erectile dysfunction with a score under 7 in the questionnaire IIEF-5 previous to the intervention

Design outcomes

Primary

Measure	Time frame
Loss of urine, measured using the 24 h Pad test and 1 h Pad test, at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months	—

Secondary

Measure	Time frame
1. Quality of life and incontinence, measured using the ICIQ-SF questionnaire at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months 2. Erectile dysfunction, measured using the International Index of Erectile Function (IIEF-5) at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months 3. Life habits, measured using a urinary diary at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months	—

Measure

Time frame

1. Quality of life and incontinence, measured using the ICIQ-SF questionnaire at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months 2. Erectile dysfunction, measured using the International Index of Erectile Function (IIEF-5) at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months 3. Life habits, measured using a urinary diary at baseline, 1 month, 2 months, 3 months (end of treatment), 6 months and 12 months

—

Countries

Spain

Contacts

Public ContactMercedes Soto-González

m.soto@uvigo.es+34 (0)986 801 750

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026